Serum syndecan-4 is associated with nonalcoholic fatty liver disease.

Shu Jing XiaLi Zhong TangWen Hua LiZhao Shan XuLi Li ZhangFeng Gan ChengHong Xia ChenZi Hua WangYu Cheng LuoAn Na DaiJian-Gao Fan

Published in: Journal of digestive diseases (2021)

Elevated serum SDC4 level is associated with metabolic disorders and the prevalence of NAFLD among general population. Serum SDC4 may serve as a biomarker of NAFLD.

Keyphrases

risk factors